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Neurotrophins and Their Receptors
Neurotrophins (NT) belong to a group of functionally and struc-
turally related proteins that were first identified as promoters for 
neuronal survival. Subsequently, it was demonstrated that they 
regulate many aspects of neuronal development and function, 
like synapse formation and synaptic plasticity.1 Nerve growth 
factor (NGF) was the first NT to be discovered during a search 
for survival factors.2 Brain-derived neurotrophic factor (BDNF) 
was the second NT to be characterized. It has been identified 
as a survival factor for several neuronal populations not respon-
sive to NGF.3 These two proteins revealed conserved features of 
the sequences, leading to isolation of clones encoding additional 
members of this family.
Nowadays, we know that four NT are expressed in mammals: 
NGF, BDNF, NT-3 NT-4. NT play a critical role in develop-
mental neurobiology. They play an essential role in cellular inter-
actions, in controlling cell survival and differentiation.4 NGF is 
internalized by receptor-dependent mechanisms and transported 
along axons in membranous vesicles and energy-dependent 
processes.5
*Correspondence to: Carlo Pincelli; Email: carlo.pincelli@unimore.it
Submitted: 11/08/10; Revised: 12/22/10; Accepted: 12/23/10
DOI: 10.4161/derm.3.1.14661
Neurotrophins (NT) belong to a family of structurally and 
functionally related proteins that, depending on the tissue 
context and the receptors involved, promote either neuronal 
cell survival and differentiation or cell death. NT, and in 
particular NGF, were first identified as neurotrophic factors 
supporting the synthesis and development of sensory neurons 
in the central and peripheral nervous system. it is now widely 
accepted that NT also act as growth factors in non-neuronal 
cells, including the skin. in the skin, most cell types are able 
to secrete and/or to respond to stimulation by NT, creating 
a unique network of molecular signaling in the cutaneous 
microenvironment. Moreover, many skin diseases have been 
associated with an involvement of a number of neural factors 
including NT, but less attention has been given to the role of 
NT as growth factors in the development of skin pathologies. 
This review summarizes currently data on the expression and 
function of NT and their receptors in several cell types in the 
skin. Moreover it focuses on the role of the skin NT network in 
two cutaneous conditions, melanoma and psoriasis where NT 
are clearly involved.
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The effects of neurotrophins are mediated by two classes of 
cell-surface receptors, a family of tyrosine kinase receptors called 
Trks (TrkA, TrkB and TrkC) and the p75 neurotrophin receptor 
(NTR). Whereas p75NTR binds all neurotrophins with low affin-
ity and specificity, Trk receptors bind neurotrophins with higher 
affinity and specificity. While TrkA binds NGF and NT-3, TrkB 
binds BDNF, NT-3, NT-4/5. TrkC only binds NT-3.
Trks are tyrosine kinase receptors, activated by ligand-induced 
formation of noncovalently associated receptor dimers. Several 
different mutation types in the trkA gene have been identified in 
congenital insensitivity to pain with anhydrosis (CIPA) patients.6 
The phenotypes associated with CIPA are believed to result in 
large part from loss of NGF-dependent neurons, including noci-
ceptive sensory and sympathetic neurons, during embryogenesis.
A dominant mutation in TrkB (Y722C) that impairs TrkB 
kinase signalling has recently been described in a patient with 
severe hyperphagic obesity and severe impairments in nocicep-
tion, learning and memory.7
NT dimerize the Trk receptors, resulting in activation through 
transphosphrylation of the kinases present in their cytoplasmic 
domains. NT interact with these receptors at the membrane-
proximal immunoglobulin-like domain. The three-dimensional 
structures of this domain in each of the Trk receptors have been 
solved.8 Expression of a specific Trk receptor confers responsive-
ness to the NT to which it binds. On the other hand the isoform 
of TrkA including an insert is also activated by NT-3 in addition 
to NGF,9 while the similar isoform of TrkB is activated by NT-3 
and NT-4 in addition to BDNF.10 Thirty-six novel isoforms 
of TrkB proteins with unique properties have been described 
recently. This suggests high complexity in the synthesis, regula-
tion and function of this important NT receptor, emphasizing 
the need for further study of these novel TrkB variants.11
TrkC has several characteristics of a tumor suppressor, and 
its expression in tumors has often been associated with good 
prognosis. TrkC was recently demonstrated to be a dependence 
receptor, transducing different positive signals in the presence of 
ligand but inducing apoptosis in the absence of ligand. Indeed, 
the TrkC ligand NT-3 (NT-3) is upregulated in a large fraction 
of aggressive human neuroblastomas (NB) and it blocks TrkC-
induced apoptosis of human NB cell lines.12,13
p75NTR was the first NT receptor to be identified as a low-
affinity receptor for NGF, but it was subsequently shown to bind 
each of the neurotrophins with a similar affinity.14,15 p75NTR is a 
member of the tumour necrosis factor receptor superfamily with 
an extra-cellular domain containing four cysteine-rich motifs, a 
single transmembrane domain and a cytoplasmic domain that 
includes a ‘death’ domain, similar to those present in other 
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keratinocytes, whereas secretion ends in more differentiated 
cells.24 NGF is able to induce proliferation in human keratino-
cytes,31 and it can either stimulate or inhibit murine epidermal 
and hair follicle keratinocyte proliferation in situ.32 Human kera-
tinocytes express the high affinity receptors TrkA and TrkC, 
but not the functional form of the TrkB.28 Inhibiting TrkA 
phosphorylation with the natural alkaloid k252a, in absence of 
exogenous NGF, reduces keratinocyte proliferation.33 This indi-
cates that endogenous NGF autocrinally sustains keratinocyte 
proliferation. Keratinocytes transfected with NGF proliferate to 
a greater extent as compared to mock cells,29 while increasing 
amounts of NT-3 antibody inhibits keratinocyte proliferation.28 
NT together with their receptors TrkA and TrkB are able to stim-
ulate mouse keratinocyte proliferation in ex-vivo cultured skin 
explants.27,32 NT also modulate susceptibility to apoptosis in the 
epidermis. While UVB downregulates both NGF and TrkA and 
induce apoptosis in human keratinocytes,29 autocrine NGF pro-
tects these cells from UVB-induced apoptosis.29 Because normal 
human keratinocytes typically lack TrkB expression, NT may 
exert different functions in this system, by binding p75NTR alone. 
In this context, p75NTR acts as a proapoptotic receptor. This is 
exemplified by BDNF and NT4, which induce a higher rate of 
apoptosis in normal human keratinocytes overexpressing p75NTR, 
as compared to mock-transfected cells. On the other hand, p75NTR 
siRNA-transfected keratinocytes fail to undergo cell death after 
administration of NT4 (Truzzi F, et al. unpublished data).
Interestingly, NGF is mostly expressed and released by stem 
keratinocytes (KSC),28 and blocking TrkA inhibits the prolifera-
tion of this keratinocyte subpopulation.28 This seems to indicate 
that a NGF-TrkA autocrine loop, by acting as both a mitogenic 
and survival factor, contributes to the maintenance of the so-
called “stemness” in keratinocytes. On the other hand, p75NTR 
is almost exclusively expressed in the more differentiated transit 
amplifying (TA) cells, and it is barely detected in KSC. TA cells 
have been shown to be more susceptible than KSC to apoptosis.34 
Therefore, p75NTR being predominantly expressed in TA cells 
seems to be consistent with the pro-apoptotic role of this recep-
tor in human keratinocytes (Truzzi F, et al. submitted). Taken 
together, these results point to a critical role of NT and their 
receptors in epidermal homeostasis.
Melanocytes. In human skin, melanocytes reside at the 
dermo-epidermal junction and in the hair matrix. During skin 
development, melanoblasts, which derive from neural crest, 
migrate into the skin and differentiate into melanocytes. Together 
with other paracrine signalling molecules, NT are important for 
melanocytes migration, viability and differentiation.35,36 Normal 
human melanocytes seem to be a target of the NT skin network, 
because they express all the NT receptors both in vitro and in 
vivo.37 Normal human melanocytes also express p75NTR, which is 
upregulated by different stimuli, like UV irradiation.38 NT influ-
ence melanocytes in paracrine fashion: for example, in vitro NGF 
is chemotactic for melanocytes and stimulate their dendrite for-
mation.26 NGF is implicated in melanocyte survival,39 migration 
and dendricity,26 and its synthesis and secretion are enhanced 
by UV irradiation.40 Moreover, when melanocytes are irradi-
ated with UV, NGF reduces apoptosis through upregulation of 
members of this family.16 Although this receptor does not contain 
a catalytic motif, it interacts with several protein that transmit 
important signals for regulating neuronal survival and differen-
tiation as well as synaptic plasticity. The three-dimensional struc-
ture of the extracellular domain of p75NTR in association with an 
NGF dimer indicates that each of the four cysteine-rich repeats 
participates in binding to NGF.16 The binding of NGF to p75NTR 
may result in dissociation of p75NTR multimers and is compat-
ible with the possibility that Trk and p75NTR monomers simul-
taneously bind the same neurotrophin dimer. A gene related to 
p75NTR, named NRH-2, has recently been identified. The prod-
uct of this gene lacks the extracellular cysteine-rich repeats pres-
ent in p75NTR and fails to bind NGF, but it is able to interact and 
influence the ligand-binding properties of TrkA.17
The role of p75NTR is still controversial: in the presence of 
Trk, p75NTR increases high-affinity NT binding, thereby enhanc-
ing the ability of Trk to promote survival.18 By contrast, in the 
absence of Trk, p75NTR can induce apoptosis, via its own signal 
transduction, by interacting with a mounting number of down-
stream molecules.19 Recently, it has been shown that the proform 
of NT proNGF binds p75NTR, in association with its co-receptor 
sortilin, but not Trk.20 More specifically, sortilin, a member of the 
vps-10 protein family, binds the ‘‘pro’’ region of NGF, whereas 
p75NTR binds mature NGF. The p75NTR-sortilin complex couples 
with proNGF to induce apoptosis.21
Neurotrophins and the Skin
NT and in particular NGF were first identified as neurotrophic 
factors supporting the synthesis and development of sensory 
neurons, that in turn extend their dendrites into the skin, thus 
playing an essential role in skin innervation. Indeed, null muta-
tions of genes from the NGF family of NT and their receptors 
(NTRs) lead to loss/reduction of specific neurons in sensory gan-
glia; conversely, cutaneous overexpression of NT results in skin 
hyperinnervation and increase in the number of sensory neurons 
innervating the skin.22 In addition, NGF synthesized in the epi-
dermis, is retrogradelly transported to the ganglia to stimulate 
the release of neuropeptides in the skin, thus favoring cutaneous 
neurogenic inflammation.23 Subsequently, it became clear that 
NGF possesses a number of biological effects also on non-neuro-
nal cells. In particular, Pincelli and co-workers first demonstrated 
that normal human keratinocytes synthesize and release NGF 
that can act as a growth factor for these cells.24 Later, expression 
and function of NGF and other NT was shown in other skin 
cells, definitely indicating that NT play very important functions 
other than supporting skin innervation. In this review, we focus 
on NT as growth factors in most cutaneous cells and report the 
concept of a rich NT network in the skin.
Keratinocytes. Human keratinocytes synthesize and secrete 
biologically active NGF,25,26 BDNF, NT-3 and NT-4.27,28 NGF is 
secreted at highest levels as compared to the other NT, whereas 
NT-3 and NGF upregulate each other’s secretion in human kera-
tinocytes. NT-3 release is augmented by UVA, whereas NGF 
expression is downregulated by UVB irradiation.29,30 In human 
skin, NGF is released in increasing amounts by proliferating 
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undergo apoptosis perinatally. These results show that NT-3 
signaling is not required for the differentiation of Merkel cells, 
but that it is essential for their postnatal survival.50 Merkel cell 
of whisker follicles of NT3 null newborns exhibited decreased 
immunoreactivity for cytokeratin 8 and contained apoptotic 
bodies that were positive for cleaved caspase-3. It was suggested 
that perinatal apoptosis is responsible for the loss of Merkel cells 
lacking innervation in NT3 null mice. TrkB was shown to be 
important for Merkel cells development, as mice lacking TrkB 
lost 32% of neurons and this neuronal loss was associated with 
the absence of Meissner corpuscles and reduction of hair follicle-
associated sensory nerve endings and Merkel cells.51 Using mice 
lacking p75NTR, indicates that Merkel cells require p75NTR during 
the late postnatal development.52
Neurotrophins in Diseased Skin
Many skin diseases have been associated with an involvement of 
a number of neural factors including NT. There is a huge body 
of literature on the increased nerve density in several dermatoses 
which has lead many investigators to conclude that augmented 
sprouting of nerves and upregulation of neuropeptide release are 
involved in the pathogenesis of certain cutaneous conditions. It 
remains to be defined whether hyperinnervation and the release 
of neural substances associated with neurogenic inflammation are 
primary phenomena or just amplification events in skin diseases.
By contrast, less attention has been given to the role of NT as 
growth factors in the development of skin pathologies. Here, we 
will review two cutaneous conditions, melanoma and psoriasis 
where NT are clearly involved.
Melanoma. Morphologically, melanomas can be subdivided 
in several subtypes, such as epithelioid, pleomorphic spindle cell 
and desmoplastic melanoma. Iwamoto et al. found that there 
was no detectable p75NTR immunostaining in melanocytes of the 
normal epidermis, whereas 13 of 14 benign nevi showed detect-
able p75NTR. This was primarily within the spindled nevocytic 
structures within the dermis.53 Interestingly, p75NTR is highly 
expressed in desmoplastic melanomas and spindle cell melano-
mas and weakly expressed in the epithelioid melanomas.54 In 
a study by Huttenbach et al. only 33% of their desmoplastic 
melanomas stained positive with p75NTR,55 while more recently 
Lazova56 showed p75NTR staining to be more diffuse and intense 
as compared with S100, as reported previously by Kanik et al.
Recently Boiko et al. showed that p75NTR (CD271), which is 
considered a neural crest stem cell marker, allows the identifica-
tion and isolation of melanoma cancer stem cells. Indeed, tumors 
derived from transplanted human CD271+ melanoma cells were 
capable of metastasizing in vivo.58 Marchetti et al. using mela-
noma cell lines, observed that NGF/p75NTR signaling promotes 
the survival of melanoma cells.59 They also observed the presence 
of NGF and NT-3 in tumor adjacent tissues at the invasive front 
of melanoma brain metastases, which might indicate a paracrine 
activation of p75NTR and TrkC in melanoma cells by NGF and 
NT-3 produced by nearby glial cells. Besides promoting mela-
noma cell survival, neurotrophins also induce the expression in 
melanoma cells of heparanase, an important enzyme for local 
the anti-apoptotic Bcl-2 protein in vivo.30 From these data it is 
possibile to conclude that NT are important for protection of 
UV-induced oxidative stress and apoptosis in melanocytes. 
Melanocytes produce all NT, while when these factors are added 
to the cultures, they fail to stimulate cell proliferation.37 When 
melanocytes are maintained in growth factor-depleted medium, 
NGF and NT-3 promote melanocyte survival.41 Both NT3 and 
NT4 secretion promotes the synthesis of tyrosinase and tyrosi-
nase-related peptide (TRP)-1, critical enzyme of melanin biosyn-
thesis.37 NT-3, NT-4 or NGF significantly increases the melanin 
content when stimulated with endotelin-1.37
Human melanocytes express Trk receptors.37,41 Interestingly, 
phorbol-12-tetradecantate-13-acetate, a strong activator of pro-
tein kinase C, induces the expression of TrkA41 and decrease 
the expression of TrkC, suggesting that NGF and NT3 medi-
ate different signals through their specific high affinity receptors. 
Melanocytes expess also the NT low affinity receptor p75NTR, 
which expression is upregulated after TPA treatment.41
Fibroblasts. NT and their receptors are expressed both in 
dermal fibroblasts and in the more differentiated myofibroblasts. 
p75NTR and TrkB are expressed at higher levels in myofibroblasts 
than in fibroblasts, which in contrast express higher levels of 
TrkA. Dermal fibroblast and myofibroblasts secrete NGF and 
NT3 at higher levels than NT4 and BDNF. Exogenous NT per se 
fail to stimulate dermal fibroblast proliferation, possibly because 
endogenous production of NT is sufficient to normal cell activ-
ity and survival. Interestingly, NT also promote fibroblast dif-
ferentiation into myofibroblasts, by inducing α-SMA expression, 
indicating that NT could have a functional role in the fibro-myo-
fibroblast system (Palazzo E, et al. manuscript in preparation). 
It has been shown that NGF induce fibroblast-like keratinocyte 
differentiation into myofibroblasts,42 their contraction in 3D col-
lagen matrix42 and the expression of MMP-9 (Metalloprotease-9) 
in keratoconjunctivitis-derived fibroblasts,43 and different works 
show the applicative possibility of this NGF function.44-46 It 
has been demonstrated that all NT promote fibroblast migra-
tion while NGF and BDNF promote their contractile activity. 
Therefore NGF and BDNF, produced by dermal and epidermal 
cells, could be key regulators of the biomechanical properties in 
the dermis.
Other skin cells. Skin mast cells express functional TrkA and 
produce NGF.47 They also express p75NTR mRNA and protein.48 
NGF has been shown to play a collaborative action on mediator 
release from residential tissue mast cells in rat skin by in vivo 
extravasation assay. This result implies that the activation path-
way in mast cells may occur in the pathophysiological condition. 
Activation of mast cells induces the release of histamine, leukot-
rienes and produces inflammatory cytokines, resulting in the 
recruitment and activation of circulating leukocytes to the area 
of allergic and non allergic inflammation.49
Merkel cells are sensory cells of neural crest origin. NT have 
been investigated during development in mice finding that nei-
ther NT-3 nor TrkC and p75NTR are expressed by Merkel cells 
in the murine whisker. At the time of birth, however, Merkel 
cells are immunoreactive for NT-3, TrkC and p75NTR. In TrkC 
null and NT-3 null mice, Merkel cells differentiate initially, but 
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for keratinocytes, is overexpressed in psoriatic lesions as well as in 
psoriatic keratinocytes,64,65 and its high-affinity receptor TrkA, 
that is located only in basal keratinocytes in healthy skin, is 
expressed throughout all epidermal layers in psoriasis.66 On the 
other hand, p75NTR that plays a proapoptotic role in keratino-
cytes, is absent in psoriatic keratinocytes. The rate of apopto-
sis in psoriatic TA cells is significantly lower as compared to TA 
cells from normal epidermis. Interestingly, TA cells from psori-
atic skin express lower levels of p75NTR as compared to TA from 
normal skin. Thus, absence of p75NTR in TA cells could account 
for the low keratinocyte apoptosis in psoriasis. In fact, infection 
of psoriatic TA with p75NTR restores apoptosis (Truzzi F, et al. 
submitted). Taken together, these results suggest that, under 
normal conditions, there is a balance between Trk and p75NTR 
functions, that allows epidermal homeostasis. On the contrary, 
in psoriasis, NGF and Trk upregulation associated with reduced 
p75NTR expression result in increased keratinocyte proliferation 
and reduced apoptosis, thus favoring epidermal thickness, a typi-
cal feature of this dermatosis. Interestingly, k252a, that has been 
shown to improve psoriasis in vivo in the SCID mouse model,67 
is now in Phase II clinical trial as a novel topical treatment for 
psoriasis.
In conclusion, NTs influence various cellular functions in 
normal and diseased skin. In the last decade, substantial progress 
has been made in the understanding of the molecular mecha-
nisms involved in NT signaling. Additional studies are necessary 
to evaluate such molecular pathways in cells from healthy and 
pathologic skin. A translation of the relevant data from the field 
of cutaneous neurobiology into clinically-oriented research will 
unravel novel therapeutic strategies for the treatment of skin dis-
eases, by targeting the skin NT network.
invasion and metastasis, that cleave heparan sulfate chains of 
proteoglycans, thus modifying the extracellular matrix of tumor 
cells.60 Moreover, Shonukan et al. established that neurotrophins 
are chemotactic for melanoma cells, triggered by p75NTR-medi-
ated dephosphorylation of the actin-bundling protein fascin.61 In 
addition, TrkA is expressed by primary and metastatic melano-
mas and is associated with poor clinical outcome.62
Melanoma originates from melanocytes. Whereas melano-
cytes seem to benefit from the cutaneous neurotrophic network 
mainly as paracrine targets, once malignant transformation 
occurs, melanoma cells acquire self-renewal capabilities medi-
ated also by autocrine NT loops. Indeed all NT, particularly 
NT-3 and NT-4, have been detected in conditioned medium of 
different melanoma cell lines.63 Recent results show that mela-
noma cells proliferate through autocrine NT stimulation. K252a 
significantly reduces melanoma cell proliferation by inhibiting 
Trk phosphorylation. Proliferation is significantly reduced when 
endogenous NT are removed from the culture medium by soluble 
Trk/Fc receptors. NT appeared to be important for melanoma 
cell migration in vitro, with special respect for metastatic cell 
lines. The migratory phenotype is necessarily dependent on the 
presence of both the high- and low-affinity NT receptors. Cells 
treated with p75NTR small interfering RNA (p75NTR siRNA) fail 
to respond to NT stimulation. Similarly, the administration of 
K252a blocks melanoma cell migration, confirming that NT 
stimulate melanoma cell migration and invasion cooperation of 
the low- and high-affinity receptors.63
Psoriasis. Psoriasis is a chronic-relapsing inflammatory 
disease characterized by keratinocyte hyperproliferation and 
reduced apoptosis, leading to an increased epidermal turnover. 
Interestingly, NGF that is both a mitogen and a survival factor 
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